Potent bradykinin antagonists containing N-benzylglycine or N-benzyl-L-alanine in position 8

Journal of Peptide Research

Volumn 63, Issue 1, 2004, Pages 29-35

  Dawidowska, O ^a   Wierzba, T H ^b   Prahl, A ^a   Kowalczyk, W ^a   Derdowska, I ^a   Neubert, K ^c   Zabrocki, J ^d   Olejniczak, B ^d   Juzwa, W ^b   Lammek, B ^a  

^a UNIVERSITY OF GDA SK   (Poland)

^b MEDICAL UNIVERSITY OF GDANSK   (Poland)

^c MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^d LODZ UNIVERSITY OF TECHNOLOGY   (Poland)

Author keywords

B2 antagonists; Bradykinin; Conformational constraints; N Benzyl L alanine; N benzylglycine; Rat blood pressure assay

Indexed keywords

ALANINE DERIVATIVE; BENZYL DERIVATIVE; BRADYKININ ACETATE; BRADYKININ ANTAGONIST; BRADYKININ DERIVATIVE; CARBOXYLIC ACID DERIVATIVE; GLYCINE DERIVATIVE; UNCLASSIFIED DRUG;

ACYLATION; AMINO TERMINAL SEQUENCE; ANIMAL EXPERIMENT; ARTICLE; CHEMICAL MODIFICATION; CONTROLLED STUDY; DOSE RESPONSE; DRUG DESIGN; DRUG DETERMINATION; DRUG POTENCY; DRUG SYNTHESIS; MALE; NONHUMAN; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; RAT;

ALANINE; ANIMALS; BLOOD PRESSURE; BRADYKININ; GLYCINE; MALE; OLIGOPEPTIDES; RATS; RATS, WISTAR;

ANIMALIA;

EID: 0842265195     PISSN: 1397002X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1399-3011.2004.00101.x     Document Type: Article

References (29)

1. Steranka, L.R., Manning, D.C., Dehas, C.J., Ferkany, J.W., Borosky, S.A., Connor, J.R., Vavrek, R.J., Stewart, J.M. & Shyder, S.H. (1988) Bradykinin as a pain mediator: receptors are localized to sensory neurons have analgesic actions. Proc. Natl. Acad. Sci U.S.A. 85, 3245-3249.
2. Proud, D. & Kaplan, A.D. (1988) Kinin formation: mechanisms and role in inflammatory disorders. Annu. Rev. Immunol. 6, 49-83.
3. Bhoola, K.D., Figueroa, C.D. & Worthy, K. (1992) Bioregulation of kinins: kallikreins, kininogens and kininases. Pharmacol. Rev. 44, 1-80.
4. Hess, J.F., Borkowski, J.A., Young, G.S., Strader, C.D. & Ramsom, R.W. (1992) Cloning and pharmacological characterization of a human bradykinin (BK-2) receptor. Biochem. Biophys. Res. Commun. 184, 260-268.
5. Menke, J.G., Borkowski, J.A., Bierilo, K.K., MacNeil, T., Derrick, A.W., Schneck, K.A., Ransom, R.W., Strader, C.D., Linemeyer, D.L. & Hess, J.F. (1994) Expression cloning of a human Bi bradykinin receptor. J. Biol. Chem. 269, 21583-21586.
6. Farmer, S.G. & Burch, R.M. (1991) The pharmacology of bradykinin receptors. In: Bradykinin Antagonists. Basic and Clinical Research (Burch, R.M., ed.), pp. 1-31. Marcel Dekker, Inc., New York-Basel-Hong Kong.
7. Vavrek, R.J. & Stewart, J.M. (1985) Competitive antagonists of bradykinin. Peptides 6, 161-164.
8. Hock, F.J., Wirth, K., Albus, U., Linz, W., Gerhards, H.J., Wiemer, G., Henke, S.T., Breipohl, G., Konig, W., Knolle, J. & Scholkens, B.A. (1991) HOE 140: a new potent and long acting bradykinin antagonist. Br. J. Pharmacol. 102, 769-773.
9. Mitchel, A.R., Young, J.D., Ghofrani, F. & Stewart, J.M. (1994) Synthesis of bradykinin analogs containing N-benzylglycine. In: Peptides Structure, Function, Biology: Proceedings of the 13th American Peptide Symposium (Hodges, R.S., ed.), pp. 427-429. Leiden, Escom.
10. Ghofrani, F., Mitchel, A.R. & Young, J.D. (1993) Use of N-benzylglycine for preparation of peptide-peptoid analogs of biologically active peptides. P323. Thirteenth American Peptide Symposium, Edmonton, Alberta, Canada.
11. Young, J.D. & Mitchel, A.R. (1990) Use of N-benzylglycine as a replacement for aromatic amino acid residues. In: Peptides: Chemistry, Structure and Biology, Proceedings of the 11th American Peptide Symposium (Rivier, J.E. & Marshal, G.R., eds), pp. 155-156. Leiden, Escom.
12. Kyle, D.J., Hicks, R.P., Blake, P.R. & Klimkowski, U.J. (1991) Conformational properties of bradykinin and bradykinin antagonists. In: Bradykinin Antagonists. Basic and Clinical Research (Burch, R.M., ed.), p. 131. Marcel Dekker, Inc., New York-Basel-Hong Kong.
13. Schachter, L.R., Uchida, Y., Longridge, D.J., Łabȩdź , T., Whalley, F.T., Vavrek, R.J. & Stewart, J.M. (1987) New synthetic antagonists of bradykinin. Br. J. Pharmacol. 91, 851.
14. 2-antagonists of bradykinin. Polish J. Chem. 68, 913-920.
15. Quitt, P., Hellerbach, J. & Vogler, K. (1963) Die synthese optisch activer N-monomethylaminosauren. Helv. Chim. Acta 47, 317-333.
16. Rowley, G., Greenleaf, A.L. & Kenyon, G.I. (1971) On the specificity of creatine kinase. New glycocynamines and glycocynamine analogs related to creatine. J. Am. Chem. Soc. 93, 5542-5551.
17. Kruijtzer John, A.W., Hofmeyer Lovina, J.F., Heerma, W., Versluis, C. & Liskamp Rob, M.J. (1998) Solid-phase syntheses of peptoids using Fmoc-protected N-substituted glycines: the synthesis of (retro) peptoids of leu-enkephalin and substance. Chem. Eur. J. 4, 1570-1580.
18. Wang, S.S. (1973) p-Alkoxybenzyl alcohol resin and p- alkoxybenzyloxycarbonyl hydrazide resin for solid phase synthesis of protected peptide fragments. J. Am. Chem. Soc. 95, 1328.
19. Jastrzȩbska, B., Derdowska, I., Kuncarowa, P., Slaninowa, J., Lammek, B., Olejnczak, B. & Zabrocki, J. (2002) Analogues of arginine vasopressin (AVP) modified in the N-terminal part of the molecule with N-benzylglycine. Polish J. Chem. 76, 823-830.
20. Lammek, B., Wang, Y.X., Gavras, I. & Gavras, H. (1991) A novel bradykinin antagonist with improved properties. J. Pharm. Pharmacol. 43, 887-888.
21. Lammek, B., Wang, Y.X., Gawras, I. & Gavras, H. (1990) A new highly potent antagonist of bradykinin. Peptides 11, 1041-1043.
22. Prahl, A., Derdowska, I., Dawidowska, O., Neubert, K., Hartrodt, B., Wierzba, T., Juzwa, W. & Lammek, B. (2002) New analogues of bradykinin substituted in the C-terminal part of the molecule with naphthylalanine. Polish J. Chem. 76, 1433-1439.
23. Prahl, A., Wierzba, T., Winklewski, P., Wszȩdybyl, M., Cherek, M., Juzwa, W. & Lammek, B. (1997) Influence of C-terminal modifications of bradykinin antagonists on their activity. Coll. Czech. Chem. Commun. 62, 1940-1946.
24. Prahl, A., Wierzba, T., Winklewski, P., Musiał, P., Juzwa, W. & Lammek, B. (1997) Antagonists of bradykinin modified with conformationally restricted dipeptide fragment. Polish J. Chem. 71, 929-935.
25. Derdowska, I., Prahl, A., Neubert, K., Hartrodt, B., Trzeciak, H.I., Klimanek, M., Winklewski, P., Wierzba, T., Juzwa, W. & Lammek, B. (2001) New bradykinin antagonists containing a conformationally restricted dipeptide fragment in their molecules. J. Pept. Res. 57, 11-18
26. Toniolo, C. (1990) Conformationally restricted peptides trough short-range cyclization. Int. J. Pept. Protein Res. 35, 287-300.
27. 1 receptor antagonist activity. J. Med. Chem. 39, 1472-1484.
28. Gera, L. & Stewart, J.M. (1996) A new class of bradykinin antagonists containing indanylglycine. Immunopharmacology 33, 174-177.
29. Prahl, A., Derdowska, I., Winklewski, P., Wierzba, T., Juzwa, W. & Lammek, B. (1996) Conformationally restricted in the C-terminal part of the molecule antagonist of bradykinin, acylated with a bulky substituent on its N-terminus. Polish J. Chem. 70, 378-381.